U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07354165) titled 'Financial Toxicity in Patients With Early-stage Breast Cancer' on Nov. 25, 2025.
Brief Summary: Non-profit, multicenter, prospective, observational study. This study aims to evaluate whether the articulated treatment algorithm that is now possible for early-stage breast cancer patients does produce tangible changes of financial distress over the time and whether the determinants of financial distress change their relative weight over the time.
Study Start Date: Sept. 30, 2025
Study Type: OBSERVATIONAL
Condition:
Breast Cancer
Intervention:
OTHER: Questionnaires
The PROFFIT questionnaire is a PRO instrument composed by 16 item...